InspireMD
NSPR
41 hedge funds and large institutions have $54.8M invested in InspireMD in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 5 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 3
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
72% more capital invested
Capital invested by funds: $31.9M → $54.8M (+$22.9M)
14% more funds holding
Funds holding: 36 → 41 (+5)
8.58% more ownership
Funds ownership: 45.9% → 54.48% (+8.6%)
50% less call options, than puts
Call options by funds: $12K | Put options by funds: $24K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$6.02M |
| 2 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$3.92M |
| 3 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$3.01M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$2.92M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.01M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$283K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
-$101K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$28.5K |
| 5 |
Morgan Stanley
New York
|
-$19.7K |
NSPR Hedge Fund Activity: Q3 2025 in Review
41 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q3 2025, worth a combined $54.8M — up 72% from $31.9M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new NSPR positions and 5 closed out — a net gain of 5 holders — while 15 added to existing stakes and 3 trimmed.
The largest buyer was Aberdeen Group, opening a new position worth an estimated $6.02M. The largest seller was Soleus Capital Management, cutting an estimated $1.01M.
- 41 institutional investors held InspireMD (NSPR) as of Q3 2025, up from 36 in Q2 2025.
- Funds reported $54.8M of InspireMD stock for Q3 2025, up 72% quarter-over-quarter.
- 10 funds opened new InspireMD positions in Q3 2025 and 5 closed out, a net change of +5 holders.
- The largest InspireMD buyer in Q3 2025 was Aberdeen Group, an estimated $6.02M added.
- The largest InspireMD seller in Q3 2025 was Soleus Capital Management, an estimated $1.01M sold.
Based on aggregated 13F filings for Q3 2025.